Sorafenib controls the epithelial‑mesenchymal transition of ovarian cancer cells via EGF and the CD44‑HA signaling pathway in a cell type‑dependent manner.
about
Sorafenib controls the epithelial‑mesenchymal transition of ovarian cancer cells via EGF and the CD44‑HA signaling pathway in a cell type‑dependent manner.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Sorafenib controls the epithel ...... a cell type‑dependent manner.
@en
Sorafenib controls the epithel ...... a cell type‑dependent manner.
@nl
type
label
Sorafenib controls the epithel ...... a cell type‑dependent manner.
@en
Sorafenib controls the epithel ...... a cell type‑dependent manner.
@nl
prefLabel
Sorafenib controls the epithel ...... a cell type‑dependent manner.
@en
Sorafenib controls the epithel ...... a cell type‑dependent manner.
@nl
P2093
P2860
P356
P1476
Sorafenib controls the epithel ...... a cell type‑dependent manner.
@en
P2093
Daejin Kim
Ga Bin Park
Hyun-Suk Ko
P2860
P304
P356
10.3892/MMR.2017.6773
P577
2017-06-14T00:00:00Z